RESTRICTED  
  
G/MA/TAR/RS/580  
 
24 January  2019 
(19-0405) Page: 1/3 
Committee on Market Access  Original: English  
 
 
RECTIFICATION AND MO DIFICATION OF SCHEDU LES 
SCHEDULE XLII - ISRAEL  
The following communication, dated 14 January 2019, is being circulated at the request of the 
delegation of Israel.  
 
_______________  
 
 
Israel  hereby submits a draft rectification to Schedule XLII - Israel pursuant to the Procedures for 
Modification and Rectification of Schedules of Tariff Concessions1.  This communication seeks to 
correct an error in Israel 's HS2012 transposition . 
 
In this regard, it should be noted that the certification in document WT/Let/1367  did not reflect the 
correct concession information for HS2012 subheading 3002.10 .  According to the amendment to 
the notes on methodology for the HS2012 transposi tion (G/MA/330/Add.1 ), HS2012 subheading 
3002.10 should retain the concessions related to the HS2007 subheading 3002.10 .  Detailed 
explanatory notes are contained in Attachment 12.  The proposed rectification to correct this error 
is contained in A ttachment  2 to this communication.2 
 
_______________  
If no objection is notified to the Secretariat within three months from the date of this document, the 
rectifications and modifications to Schedule XLII - Israel will be deemed to be approved and will be  
formally  certified.  
 
 
                                                
1 Decision of  26 March 1980, GATT BISD  27S/25.  
2 In English only.   
  G/MA/TAR/RS/580  
 
- 2 - ATTACHMENT  1 – EXPLANATORY NOTE  
According to the methodology followed by the Secretariat in document G/MA/330 , a simplification should be used for the transposition of HS2012 
subheading 3002.10.  Further to comments from other Members , an amendment to the simplification of this subheading was adopted by the 
Committee on Market Access in G/MA/330/Add.1 . In this document, t he Secretariat suggest ed for HS2012 subheading 3002.10 to retain the 
concessions related to the HS2007 subheading 300 2.10 instead of using the mode of the candidate lines . This amendment was not reflected in 
Israel's HS2012 transposition certified in WT/Let/1367.  As a result, t he following correction is required to reflect the amendment : 
WT/Let/ 1367   Proposed Rectificat ion 
Existing 
HS2012  
code  Existing Product Description  Existing 
Final  
Bound 
Rate  Proposed 
HS2012  code  Proposed Product Description  Proposed 
Final  
Bound Rate  
30021000  - Antisera, other blood fractions and 
immunological products, whether or 
not modified or obtained by means 
of biotechnological processes  5  300210  - Antisera, other blood fractions 
and immunological products, 
whether or not modified or 
obtained by means of 
biotechnological processes   
 30021010  - - Tetanus immune globine 
human  8 
 30021090  - - Other  5 
*Bold represents the revision  
  
  G/MA/TAR/RS/580  
 
- 3 - ATTACHMENT 2 – DRAFT  RECTIFICATION  
SCHEDULE XLII - ISRAEL  
PART I - MOST -FAVOURED NATION TARIFF  
SECTION II – Other Products  
 
Tariff item  
(HS20 12) Description of Products  Base rate  
 of duty  Bound rate  
of duty  Implementation 
period from/to 
(*) Initial 
Negotiating 
Right  Other duties 
and charges  
300210  - Antisera, other blood fractions and 
immunological products, whether or not 
modified or obtained by means of 
biotechnological processes       
30021010  - - Tetanus immune globine human   8   0 
30021090  - - Other   5   0 
 
__________